Case Report
Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host
Published: February 14, 2014
Genet. Mol. Res. 13 (4) : 9308-9314
DOI: https://doi.org/10.4238/2014.February.14.8
Cite this Article:
W.X. Qu, X.W. Feng, L. Zhao (2014). Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host. Genet. Mol. Res. 13(4): 9308-9314. https://doi.org/10.4238/2014.February.14.8
896 views
Abstract
Immunocompromised individuals are susceptible to pulmonary Aspergillus infections, whereas invasive Aspergillus infection is extremely rare in the presence of normal immunity. A case of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent 57-year-old female host who was successfully treated with amphotericin-B and voriconazole is reported here.
Immunocompromised individuals are susceptible to pulmonary Aspergillus infections, whereas invasive Aspergillus infection is extremely rare in the presence of normal immunity. A case of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent 57-year-old female host who was successfully treated with amphotericin-B and voriconazole is reported here.
Download: